Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
about
Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical ImplicationsTranscription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) GeneCancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry?TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumorsOncogenic mutation profiling in new lung cancer and mesothelioma cell lines.TERT promoter mutations are associated with distant metastases in upper tract urothelial carcinomas and serve as urinary biomarkers detected by a sensitive castPCRClinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinomaUnderstanding TERT Promoter Mutations: A Common Path to Immortality.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.KMT2A promotes melanoma cell growth by targeting hTERT signaling pathway.High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma.Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.Telomere Maintenance Mechanisms in Cancer.
P2860
Q26738705-CFB5218D-3426-4BB8-975B-F468BC6CCB86Q26739925-4685320F-93C7-4956-A0A4-F99E37647202Q30459452-8870EDE2-B62F-4F86-8E41-14BAA075B2BAQ33687535-0C04B3AC-02A6-4020-82D5-94088283734DQ33688439-40750AB4-B9BB-4F1B-8AA1-3B98ACEE68FFQ33709979-3FB68FC8-87B6-402D-980E-90649D77D0F5Q35001781-2AA38674-F13C-44E4-9E2C-25A4ECA4A3E7Q35068013-9CB1A42A-AFEC-4FD7-BE9E-7D62FBF2A809Q35901458-E3B74D68-0F52-45CF-ABFE-4998D6B22E73Q37626548-EF2A3917-2ADA-4ECF-AC23-62DEE982C30FQ38760235-A31DF63E-8A9C-4DC9-8E59-397AA1794A16Q38972707-29B4B543-2E69-48EE-BA49-497355817C1CQ39076273-B4C2EFE0-E280-4CB4-B694-1039BC0EFBF6Q40857012-9B678EFB-F3FF-4DBD-9D54-BE9A9D22579CQ41335241-DD2F69FC-8522-46A0-888A-D24BEB3D91E0Q48857394-8DF9FC3B-5F8E-4E24-96DC-50F8ABFCCCC6Q49232092-D60E2E90-AF31-4653-871D-35EE8F511914Q52956152-226DDBA0-BB57-4005-815A-AA5C93EFA78AQ53232555-DB2136D5-5D05-45BA-B741-07A4A0F7CB97Q55443450-F9CAE473-0415-4F9D-AA7C-24A6673F8F63
P2860
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@en
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@nl
type
label
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@en
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@nl
prefLabel
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@en
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2013.351
P407
P50
P577
2013-08-26T00:00:00Z